Darnytsia Held a Meeting with Representatives of the State Expert Centre of the Ministry of Health of Ukraine

Pharmaceutical Company ‘Darnytsia’ met a delegation of the State Expert Centre of the Ministry of Health of Ukraine (SEC) and offered a production tour.

During the meeting, the members of the delegation were introduced to the business processes and priorities of the company.

First, Darnytsia intends to meet the needs of patients in emerging markets through rational and advanced pharmacotherapy.

Secondly, it intends to become an absolute leader in cardiology, neurology, and pain management in Ukraine and abroad.  

Thirdly, it plans to stimulate innovation and digitalization: from the development of complex generics, the creation of new sales models to the digitalization of the entire organization and the creation of services with added value for patients and doctors.

During the meeting, representatives of SEC, which is an important link in the health care system and the regulation of medicines in Ukraine, were introduced to the production facilities of Darnytsia and the use of advanced technologies in the production of medicines.

As part of the visit, representatives of both sides exchanged practical questions and their ideas on improving work in the context of a full-scale war. 

‘We are happy to show the SEC experts the capabilities of our business, which are really impressive. High-tech, innovation, and readiness to act, despite external circumstances, are the main prerequisites for the sustainability and further development of Darnytsia. We have ambitious plans and are ready to implement them’, Kateryna Turlina, Head of the Ukrainian Registration Department at Darnytsia, said.

For their part, the SEC experts thanked for the meeting and the opportunity to get acquainted with good practices in the production of domestic medicines in compliance with international standards.